<VariationArchive VariationID="3254075" VariationName="NM_005359.6(SMAD4):c.737del (p.Pro246fs)" VariationType="Deletion" Accession="VCV003254075" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-23" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1454292" VariationID="3254075">
      <GeneList>
        <Gene Symbol="SMAD4" FullName="SMAD family member 4" GeneID="4089" HGNC_ID="HGNC:6770" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51030213" stop="51085042" display_start="51030213" display_stop="51085042" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48556582" stop="48611411" display_start="48556582" display_stop="48611411" Strand="+" />
          </Location>
          <OMIM>600993</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMAD4">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_005359.6(SMAD4):c.737del (p.Pro246fs)</Name>
      <CanonicalSPDI>NC_000018.10:51058192:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="51058193" stop="51058193" display_start="51058193" display_stop="51058193" variantLength="1" positionVCF="51058192" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="48584563" stop="48584563" display_start="48584563" display_stop="48584563" variantLength="1" positionVCF="48584562" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>P246fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_318" sequenceAccession="LRG_318">
            <Expression>LRG_318:g.95155del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.51058194del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.51058194del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.48584564del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.48584564del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013013.2" sequenceAccession="NG_013013" sequenceVersion="2" change="g.95155del">
            <Expression>NG_013013.2:g.95155del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005359.6" sequenceAccession="NM_005359" sequenceVersion="6" change="c.737del" MANESelect="true">
            <Expression>NM_005359.6:c.737del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005350.1" sequenceAccession="NP_005350" sequenceVersion="1" change="p.Pro246fs">
            <Expression>NP_005350.1:p.Pro246fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2144427288" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005359.6(SMAD4):c.737del (p.Pro246fs) AND Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome" Accession="RCV004589030" Version="1">
        <ClassifiedConditionList TraitSetID="2354">
          <ClassifiedCondition DB="MedGen" ID="C1832942">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-05-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-05-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2354" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2502" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">JP/HHT SYNDROME</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JUVENILE POLYPOSIS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYPOSIS, GENERALIZED JUVENILE, WITH PULMONARY ARTERIOVENOUS MALFORMATION</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TELANGIECTASIA, HEREDITARY HEMORRHAGIC, WITH JUVENILE POLYPOSIS COLI</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis-hereditary+hemorrhagic+telangiectasia+syndrome/8700" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008278" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JP/HHT</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JPS/HHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">JPHT</ElementValue>
                <XRef Type="MIM" ID="175050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SMAD4-Related Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C1832942" DB="MedGen" />
              <XRef ID="MONDO:0008278" DB="MONDO" />
              <XRef Type="MIM" ID="175050" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9865691" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="100453544|OMIM:175050" />
        <ClinVarAccession Accession="SCV005084365" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-05-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMAD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="18" alternateAllele="C" referenceAllele="CC" start="48584563" stop="48584564" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">100453544</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="175050" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14610925</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9865691" TraitType="Disease" MappingType="XRef" MappingValue="175050" MappingRef="OMIM">
        <MedGen CUI="C1832942" Name="Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

